Federal law mandating comprehensive care of breast cancer patients
Provision of this bill requires carriers who do not provide coverage for a set minimum length of hospitalization for mastectomy and testicle removal procedures to provide home visits within 24 hours after discharge.
A second visit must be provided, if requested by the doctor.
Cancer patients at Johns Hopkins undergo insurance clearance to verify coverage for enrollment to interventional clinical trials.
We sought to explore the impact of insurance clearance on disparities in access to cancer clinical trials at this urban comprehensive cancer center.
Residents of Pennsylvania, which lacks a state law mandating cancer clinical trial coverage for residents, were overrepresented among the denied patients (P = 0.0009).This enrolled bill requires health insurers and health maintenance organizations to provide a baseline mammogram for women 35-39, a mammogram every two years for women 40-49, and an annual mammogram for women 50 years of age and older.The following link possibly updates HB 407. law passed requiring the Maryland Department of Health and Mental Hygiene to provide all physicians who perform breast implantation in Maryland with a booklet that describes the advantages, disadvantages and risks associated with breast implantation.ope of specified provisions of law relating to coverage of cancer chemotherapy to include specified policies or contracts issued or delivered by specified entities that provide essential health benefits required under specified provisions of federal law; making the Act an emergency measure; etc.
Requiring the Department of Health and Mental Hygiene, in consultation with the Department of the Environment, to convene a workgroup to examine issues relating to the investigation of potential cancer clusters in the State and potential environmental causes of cancer; specifying issues to be examined; requiring the workgroup to include specified legislators and representatives; requiring the Department of Health and Mental Hygiene to report findings and recommendations of the workgroup on or before June 30, 2014; etc.
Prohibiting insurers, nonprofit health service plans, and health maintenance organizations that provide coverage for cancer chemotherapy under specified health insurance policies or contracts from imposing limits or cost sharing on coverage for orally administered cancer chemotherapy that are less favorable to an insured or enrollee than the limits or cost sharing on coverage for cancer chemotherapy that is administered intravenously or by injection; etc.